GB34 Acupuncture in Acute Cholecystitis

Status Recruiting

Clinical Trial Summary

The purpose of this pilot study is to investigate the effects of GB34 acupuncture, performed as adjuvant to standard medical treatment, on clinical response and laboratory parameters of patients with a diagnosis of acute cholecystitis.

Clinical Trial Description

Acute cholecystitis is a frequent complication of gallbladder stones. The prevalence of gallbladder stone is 10-15% and in 35% of patients complications and recurrent symptoms develop in their lifetime. Acute cholecystitis is one of the most frequently encountered acute surgical conditions. It is manifested in 3-10% of patients referred to emergency departments with complaints of abdominal pain. Although the gold standard of therapy is laparoscopic cholecystectomy in symptomatic cholecystitis and related complications, more than 70% of patients respond well to medical treatment at first place. Actually, timing of cholecystectomy was studied extensively, yet is still debatable. Early cholecystectomy is the operation performed within 72 hours of the beginning of the symptoms. Delayed cholecystectomy is the operation performed 6 weeks after the suppression of the inflammation. Investigators perform early cholecystectomy is in cases with perforation and complication like gangrenous or emphysematous acute cholecystitis whereas delayed cholecystectomy is preferred in the remaining patients. In fact it is known for some time that ear and body acupuncture have modulatory effects on motor functions of gallbladder and even provide some improvement in acute cholecystitis. Previously, studies demonstrating that GB34 has specific effects on the motility of bile ducts were published. More recently, researchers were able to demonstrate that GB34 electro acupuncture have positive effects on gall bladder wall thickness and on WBC levels, by using an experimental rabbit model of acute cholecystitis. Additional functional MR studies were used to distinguish the neural specificity of the acupuncture points. GB34 were found to induce a specific response pattern which is more significant in motor functions in brain. Furthermore it is known for decades that acupuncture other than point specific effects, triggers self-healing mechanisms of the body via endogen pathways. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04960189
Study type	Interventional
Source	Nigde Omer Halisdemir University
Contact	Aliriza Erdogan, MD
Phone	05333558377
Email	alirizaerdogan@ohu.edu.tr
Status	Recruiting
Phase	N/A
Start date	July 1, 2021
Completion date	July 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04156711` - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery	N/A
Recruiting	`NCT02130245` - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study	N/A
Completed	`NCT01942356` - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor	N/A
Completed	`NCT04995380` - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed	`NCT03999645` - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days?	N/A
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03002051` - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent	N/A
Completed	`NCT00447304` - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy	Phase 3
Completed	`NCT04346550` - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain	N/A
Active, not recruiting	`NCT04197908` - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.	N/A
Completed	`NCT02027402` - Effects of Drainage in Laparoscopic Cholecystectomy	N/A
Not yet recruiting	`NCT01706068` - Transient ECG Changes in Patients With Acute Biliary Disease	N/A
Enrolling by invitation	`NCT04633512` - Safety and Feasibility of ActivSightTM in Human	N/A
Completed	`NCT04672902` - Treatment of Mirizzi Syndrome
Completed	`NCT03122054` - Early Versus Delayed Cholecystectomy	N/A
Recruiting	`NCT05732480` - Influence of Gut Microbiome in Gallstone Disease
Completed	`NCT04308265` - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting	`NCT06287112` - Prevention of Acute Cholecystitis With ETGBD	N/A
Recruiting	`NCT05709548` - Use of Indocyanine Green in Acute Cholecystitis	Phase 4
Not yet recruiting	`NCT06459323` - the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?!	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.